Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential Female Response to THC
NCT03809546Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Nov 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol (3 arms), sponsored by University of Chicago. Primary endpoint: Profile of Mood States. Started Nov 2018; status: completed.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT03809546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809546.